Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 8;11(9):e37288.
doi: 10.2196/37288.

A Mobile Phone App for the Prevention of Type 2 Diabetes in Malaysian Women With Gestational Diabetes Mellitus: Protocol for a Feasibility Randomized Controlled Trial

Madeleine Benton  1 , Iklil Iman  2 , Kimberley Goldsmith  3 , Angus Forbes  4 , Siew Mooi Ching  2 , Iliatha Papachristou Nadal  1 , Nicola Guess  5 , Helen R Murphy  6 , Barakatun-Nisak Mohd Yusof  7 , Anisah Baharom  8 , Nur Hafizah Mahamad Sobri  2 , Nurul Iftida Basri  9 , Mazatulfazura Sf Salim  10 , Irmi Zarina Ismail  2 , Faezah Hassan  2 , Khalida Ismail  1 , Boon How Chew  2   11
Affiliations

A Mobile Phone App for the Prevention of Type 2 Diabetes in Malaysian Women With Gestational Diabetes Mellitus: Protocol for a Feasibility Randomized Controlled Trial

Madeleine Benton et al. JMIR Res Protoc. .

Abstract

Background: Over 50% of women with a history of gestational diabetes mellitus (GDM) will develop type 2 diabetes (T2D) in later life. Asian women experience a disproportionate risk of both GDM and T2D compared to women from other ethnic backgrounds. Lifestyle interventions and behavior change can delay or even prevent the onset of T2D. We have developed a digitalized diabetes prevention intervention for the prevention of T2D in Malaysian women with GDM.

Objective: The protocol describes a randomized controlled trial (RCT) to test the feasibility of undertaking a definitive trial of a diabetes prevention intervention, including a smartphone app and group support. Secondary aims are to summarize anthropometric, biomedical, psychological, and lifestyle outcomes overall and by allocation group, and to undertake a process evaluation.

Methods: This is a two-arm parallel feasibility RCT. A total of 60 Malaysian women with GDM will be randomized in the antenatal period to receive the intervention or standard care until 12 months post partum. The intervention is a diabetes prevention intervention delivered via a smartphone app developed based on the Information-Motivation-Behavioral Skills model of behavior change and group support using motivational interviewing. The intervention provides women with tailored information and support to encourage weight loss through adapted dietary intake and physical activity. Women in the control arm will receive standard care. The Malaysian Ministry of Health's Medical Research and Ethics Committee has approved the trial (NMRR-21-1667-60212).

Results: Recruitment and enrollment began in February 2022. Future outcomes will be published in peer-reviewed health-related research journals and presented at national, regional, or state professional meetings and conferences. This publication is based on protocol version 2, January 19, 2022.

Conclusions: To our knowledge, this will be the first study in Malaysia that aims to determine the feasibility of a digital intervention in T2D prevention among women with GDM. Findings from this feasibility study will inform the design of a full-scale RCT in the future.

Trial registration: ClinicalTrials.gov NCT05204706; https://clinicaltrials.gov/ct2/show/NCT05204706.

International registered report identifier (irrid): PRR1-10.2196/37288.

Keywords: diabetes prevention; gestational diabetes mellitus; mobile app; randomized controlled trial.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: NG has received consulting fees from Oviva and Fixing Dad for app development for type 2 diabetes management programs. All other authors declare no conflicts.

Figures

Figure 1
Figure 1
Study flow diagram. GDM: gestational diabetes mellitus; T1D: type 1 diabetes; T2D: type 2 diabetes.
See this image and copyright information in PMC

References

    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009 Jan;32 Suppl 1:S62–7. doi: 10.2337/dc09-S062. http://europepmc.org/abstract/MED/19118289 32/Supplement_1/S62 - DOI - PMC - PubMed
    1. Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016 Jan;16(1):7. doi: 10.1007/s11892-015-0699-x. http://europepmc.org/abstract/MED/26742932 10.1007/s11892-015-0699-x - DOI - PMC - PubMed
    1. Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019 Jun;62(6):905–914. doi: 10.1007/s00125-019-4840-2.10.1007/s00125-019-4840-2 - DOI - PubMed
    1. Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016 Jul;59(7):1396–1399. doi: 10.1007/s00125-016-3985-5.10.1007/s00125-016-3985-5 - DOI - PubMed
    1. HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJN, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008 May 08;358(19):1991–2002. doi: 10.1056/NEJMoa0707943.358/19/1991 - DOI - PubMed

Associated data